Annual accounts receivable:
$272.37M+$13.04M(+5.03%)Summary
- As of today (September 19, 2025), IART annual accounts receivable is $272.37 million, with the most recent change of +$13.04 million (+5.03%) on December 31, 2024.
- During the last 3 years, IART annual accounts receivable has risen by +$29.13 million (+11.97%).
- IART annual accounts receivable is now -4.09% below its all-time high of $283.98 million, reached on December 31, 2019.
Performance
IART Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$284.51M+$32.06M(+12.70%)Summary
- As of today (September 19, 2025), IART quarterly accounts receivable is $284.51 million, with the most recent change of +$32.06 million (+12.70%) on June 30, 2025.
- Over the past year, IART quarterly accounts receivable has increased by +$6.73 million (+2.42%).
- IART quarterly accounts receivable is now -4.05% below its all-time high of $296.51 million, reached on June 30, 2019.
Performance
IART Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IART Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.0% | +2.4% |
| 3 y3 years | +12.0% | +14.8% |
| 5 y5 years | -4.1% | +52.5% |
IART Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | +12.0% | at high | +14.8% |
| 5 y | 5-year | -4.1% | +16.9% | at high | +52.5% |
| alltime | all time | -4.1% | +8669.2% | -4.0% | +9547.6% |
IART Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $284.51M(+12.7%) |
| Mar 2025 | - | $252.45M(-7.3%) |
| Dec 2024 | $272.37M(+5.0%) | $272.37M(+6.3%) |
| Sep 2024 | - | $256.13M(-7.8%) |
| Jun 2024 | - | $277.78M(+11.8%) |
| Mar 2024 | - | $248.57M(-4.1%) |
| Dec 2023 | $259.33M(-5.2%) | $259.33M(-2.8%) |
| Sep 2023 | - | $266.66M(-0.6%) |
| Jun 2023 | - | $268.30M(+1.6%) |
| Mar 2023 | - | $264.06M(-3.5%) |
| Dec 2022 | $273.59M(+12.5%) | $273.59M(+7.5%) |
| Sep 2022 | - | $254.55M(+2.7%) |
| Jun 2022 | - | $247.93M(+0.7%) |
| Mar 2022 | - | $246.23M(+1.2%) |
| Dec 2021 | $243.24M(+4.4%) | $243.24M(+5.5%) |
| Sep 2021 | - | $230.61M(-3.0%) |
| Jun 2021 | - | $237.78M(+3.4%) |
| Mar 2021 | - | $230.04M(-1.3%) |
| Dec 2020 | $232.96M(-18.0%) | $232.96M(+3.6%) |
| Sep 2020 | - | $224.84M(+20.5%) |
| Jun 2020 | - | $186.54M(-26.4%) |
| Mar 2020 | - | $253.49M(-10.7%) |
| Dec 2019 | $283.98M(+6.9%) | $283.98M(+1.0%) |
| Sep 2019 | - | $281.12M(-5.2%) |
| Jun 2019 | - | $296.51M(+6.2%) |
| Mar 2019 | - | $279.07M(+5.0%) |
| Dec 2018 | $265.74M(+5.5%) | $265.74M(+6.8%) |
| Sep 2018 | - | $248.74M(-3.7%) |
| Jun 2018 | - | $258.38M(-5.1%) |
| Mar 2018 | - | $272.26M(+8.1%) |
| Dec 2017 | $251.80M(+69.9%) | $251.80M(+47.1%) |
| Sep 2017 | - | $171.13M(-0.1%) |
| Jun 2017 | - | $171.32M(+8.3%) |
| Mar 2017 | - | $158.23M(+6.8%) |
| Dec 2016 | $148.19M | $148.19M(+5.3%) |
| Sep 2016 | - | $140.75M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $145.57M(-4.0%) |
| Mar 2016 | - | $151.61M(+14.6%) |
| Dec 2015 | $132.24M(+0.2%) | $132.24M(+5.4%) |
| Sep 2015 | - | $125.47M(-6.7%) |
| Jun 2015 | - | $134.55M(+6.1%) |
| Mar 2015 | - | $126.78M(-3.9%) |
| Dec 2014 | $131.92M(+11.7%) | $131.92M(+9.3%) |
| Sep 2014 | - | $120.74M(+2.1%) |
| Jun 2014 | - | $118.26M(+5.1%) |
| Mar 2014 | - | $112.52M(-4.8%) |
| Dec 2013 | $118.14M(+2.8%) | $118.14M(+4.1%) |
| Sep 2013 | - | $113.54M(-1.1%) |
| Jun 2013 | - | $114.75M(+2.5%) |
| Mar 2013 | - | $111.94M(-2.6%) |
| Dec 2012 | $114.92M(-2.7%) | $114.92M(-3.9%) |
| Sep 2012 | - | $119.53M(+3.4%) |
| Jun 2012 | - | $115.57M(+1.4%) |
| Mar 2012 | - | $114.00M(-3.5%) |
| Dec 2011 | $118.13M(+11.4%) | $118.13M(+0.3%) |
| Sep 2011 | - | $117.78M(+1.4%) |
| Jun 2011 | - | $116.18M(+9.5%) |
| Mar 2011 | - | $106.12M(+0.1%) |
| Dec 2010 | $106.00M(+2.7%) | $106.00M(-1.1%) |
| Sep 2010 | - | $107.15M(+9.6%) |
| Jun 2010 | - | $97.78M(+237.9%) |
| Dec 2009 | $103.23M(-8.2%) | - |
| Dec 2008 | $112.42M(+8.6%) | - |
| Dec 2007 | $103.54M(+21.8%) | - |
| Dec 2006 | $85.02M(+73.5%) | - |
| Dec 2005 | $49.01M(+4.8%) | - |
| Dec 2004 | $46.77M(+61.6%) | - |
| Dec 2003 | $28.94M(+49.1%) | $28.94M(+49.1%) |
| Dec 2002 | $19.41M(+38.4%) | $19.41M(+525.0%) |
| Dec 2001 | $14.02M(+351.5%) | - |
| Dec 1998 | $3.11M | $3.11M(+5.3%) |
| Sep 1998 | - | $2.95M |
FAQ
- What is Integra LifeSciences Holdings Corporation annual accounts receivable?
- What is the all time high annual accounts receivable for Integra LifeSciences Holdings Corporation?
- What is Integra LifeSciences Holdings Corporation annual accounts receivable year-on-year change?
- What is Integra LifeSciences Holdings Corporation quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Integra LifeSciences Holdings Corporation?
- What is Integra LifeSciences Holdings Corporation quarterly accounts receivable year-on-year change?
What is Integra LifeSciences Holdings Corporation annual accounts receivable?
The current annual accounts receivable of IART is $272.37M
What is the all time high annual accounts receivable for Integra LifeSciences Holdings Corporation?
Integra LifeSciences Holdings Corporation all-time high annual accounts receivable is $283.98M
What is Integra LifeSciences Holdings Corporation annual accounts receivable year-on-year change?
Over the past year, IART annual accounts receivable has changed by +$13.04M (+5.03%)
What is Integra LifeSciences Holdings Corporation quarterly accounts receivable?
The current quarterly accounts receivable of IART is $284.51M
What is the all time high quarterly accounts receivable for Integra LifeSciences Holdings Corporation?
Integra LifeSciences Holdings Corporation all-time high quarterly accounts receivable is $296.51M
What is Integra LifeSciences Holdings Corporation quarterly accounts receivable year-on-year change?
Over the past year, IART quarterly accounts receivable has changed by +$6.73M (+2.42%)